GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Apex Biotechnology Corp (TPE:1733) » Definitions » Cyclically Adjusted Book per Share

Apex Biotechnology (TPE:1733) Cyclically Adjusted Book per Share : NT$20.89 (As of Mar. 2024)


View and export this data going back to 2001. Start your Free Trial

What is Apex Biotechnology Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Apex Biotechnology's adjusted book value per share for the three months ended in Mar. 2024 was NT$17.177. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is NT$20.89 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Apex Biotechnology's average Cyclically Adjusted Book Growth Rate was -0.30% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 2.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Apex Biotechnology was 2.70% per year. The lowest was 2.60% per year. And the median was 2.65% per year.

As of today (2024-06-11), Apex Biotechnology's current stock price is NT$33.50. Apex Biotechnology's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was NT$20.89. Apex Biotechnology's Cyclically Adjusted PB Ratio of today is 1.60.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Apex Biotechnology was 1.92. The lowest was 0.98. And the median was 1.27.


Apex Biotechnology Cyclically Adjusted Book per Share Historical Data

The historical data trend for Apex Biotechnology's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Apex Biotechnology Cyclically Adjusted Book per Share Chart

Apex Biotechnology Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 19.26 19.20 20.21 20.87 20.75

Apex Biotechnology Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.95 21.01 21.01 20.75 20.89

Competitive Comparison of Apex Biotechnology's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, Apex Biotechnology's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Apex Biotechnology's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Apex Biotechnology's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Apex Biotechnology's Cyclically Adjusted PB Ratio falls into.



Apex Biotechnology Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Apex Biotechnology's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book= Book Value per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=17.177/131.7762*131.7762
=17.177

Current CPI (Mar. 2024) = 131.7762.

Apex Biotechnology Quarterly Data

Book Value per Share CPI Adj_Book
201406 17.475 100.560 22.900
201409 18.114 100.428 23.768
201412 18.955 99.070 25.213
201503 19.222 99.621 25.426
201506 17.217 100.684 22.534
201509 18.524 100.392 24.315
201512 19.432 99.792 25.660
201603 20.130 100.470 26.402
201606 18.640 101.688 24.155
201609 18.657 101.861 24.136
201612 17.369 101.863 22.470
201703 16.952 102.862 21.717
201706 16.032 103.349 20.442
201709 16.246 104.136 20.558
201712 16.692 104.011 21.148
201803 16.967 105.290 21.235
201806 16.139 106.317 20.004
201809 16.851 106.507 20.849
201812 16.471 105.998 20.477
201903 16.775 107.251 20.611
201906 16.175 108.070 19.723
201909 16.008 108.329 19.473
201912 16.766 108.420 20.378
202003 16.877 108.902 20.422
202006 16.010 108.767 19.397
202009 16.235 109.815 19.482
202012 16.557 109.897 19.853
202103 16.902 111.754 19.930
202106 17.252 114.631 19.832
202109 16.699 115.734 19.014
202112 17.536 117.630 19.645
202203 18.016 121.301 19.572
202206 17.035 125.017 17.956
202209 17.725 125.227 18.652
202212 18.182 125.222 19.134
202303 17.136 127.348 17.732
202306 17.416 128.729 17.828
202309 17.811 129.860 18.074
202312 17.973 129.419 18.300
202403 17.177 131.776 17.177

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Apex Biotechnology  (TPE:1733) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Apex Biotechnology's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=33.50/20.89
=1.60

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Apex Biotechnology was 1.92. The lowest was 0.98. And the median was 1.27.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Apex Biotechnology Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Apex Biotechnology's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Apex Biotechnology (TPE:1733) Business Description

Industry
Traded in Other Exchanges
N/A
Address
No.7, Li-Hsin 5th Road, Hsinchu Science Park, Hsinchu, TWN, 30078
Apex Biotechnology Corp engages mainly in research, development, production, manufacturing and selling of biochemical testing instruments and its detection strips, and trade of products and components relevant to the core business. The company develops and markets biosensor-based blood glucose monitoring systems. The company manufactures non-invasive diagnostic technologies, IT-based telehealth care and molecular diagnostic and traditional Chinese medicine. Its product offerings include Eclipse plus multipurpose analyzer, Glucosure HT blood glucose monitoring system, HemoSmart GOLD hemoglobin screening system among others.

Apex Biotechnology (TPE:1733) Headlines

No Headlines